Evidence map›Paper›PMID 37333682›Full record

ArticleInfection and drug resistance2023

Infection Prevalence at a Tertiary Hospital in Hail, Saudi Arabia: A Single-Center Study to Identify Strategies to Improve Antibiotic Usage.

Muteb Alanazi, Hassan Mohammed Alqahtani, Mohammad Khalid Alshammari, Raad Mohammed Alshammari, Jonaid Ahmad Malik, Sakeel Ahmed, Mir Aroosa, Mrunal Shinde, Tareq Nafea Alharby, Mukhtar Ansari and 3 more

Open access · goldAbstract read
In one paragraph

Article in Infection and drug resistance, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.9field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 5 citations in OpenAlex.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 5 institutions in 2 countries.

Muteb AlanaziDepartment of Clinical Pharmacy, College of Pharmacy, University of Hail, Hail, Saudi Arabia.
Hassan Mohammed AlqahtaniDepartment of Clinical Pharmacy, College of Pharmacy, University of Hail, Hail, Saudi Arabia.
Mohammad Khalid AlshammariDepartment of Clinical Pharmacy, College of Pharmacy, University of Hail, Hail, Saudi Arabia.
Raad Mohammed AlshammariDepartment of Clinical Pharmacy, College of Pharmacy, University of Hail, Hail, Saudi Arabia.
Jonaid Ahmad MalikDepartment of Pharmacology and Toxicology, National Institute of Pharmaceutical Education and Research, Guwahati, India.
Sakeel AhmedDepartment of Pharmacology and Toxicology, National Institute of Pharmaceutical Education and Research, Ahmedabad, India.
Mir AroosaDepartment of Pharmacology and Toxicology, Jamia Hamdard, New Delhi, India.
Mrunal ShindeDepartment of Pharmaceutical Analysis, National Institute of Pharmaceutical Education and Research, Guwahati, India.
Tareq Nafea AlharbyDepartment of Clinical Pharmacy, College of Pharmacy, University of Hail, Hail, Saudi Arabia.
Mukhtar AnsariDepartment of Clinical Pharmacy, College of Pharmacy, University of Hail, Hail, Saudi Arabia.ORCID 0000-0002-5247-6356
Arshad HussainDepartment of Clinical Pharmacy, College of Pharmacy, University of Hail, Hail, Saudi Arabia.ORCID 0000-0002-1588-2566
Fahad F AlkhrshawyPharmaceutical Care Department, Hail General Hospital - Hail Health Cluster, Hail, Saudi Arabia.
Sirajudheen AnwarDepartment of Pharmacology and Toxicology, College of Pharmacy, University of Hail, Hail, Saudi Arabia.ORCID 0000-0002-0926-2790
University of Ha'il · SAIndian Institute of Technology Ropar · INJamia Hamdard · INNational Institute of Pharmaceutical Education and Research · INNational Institute of Pharmaceutical Education and Research (NIPER) - Ahmedabad · IN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Objective: Identifying the burden of disease and the condition of the Saudi population is in high demand from both a surveillance and analytical standpoint. The objective of this study was to determine the most prevalent infections among hospitalized patients (both community-acquired and hospital-acquired), the antibiotics prescribing pattern, and their relationship with patient characteristics like age and gender. Methods: A retrospective study was conducted comprising 2646 patients with infectious diseases or complications admitted to a tertiary hospital in the Hail region of Saudi Arabia. A standardized form was used to collect information from patient's medical records. Demographic data such as age, gender, prescribed antibiotics, and culture-sensitivity tests were included in the study. Results: Males represented about two-thirds (66.5%, n = 1760) of the patients. Most patients (45.9%) who suffered from infectious diseases were between the ages of 20 and 39. The most prevalent infectious ailment was respiratory tract infection (17.65%, n = 467). Furthermore, the most common multiple infectious diseases were gallbladder calculi with cholecystitis (40.3%, n = 69). Similarly, COVID-19 had the greatest impact on people over 60. Beta-lactam antibiotics were the most commonly prescribed (37.6%), followed by fluoroquinolones (26.26%) and macrolides (13.45%). But performing culture sensitivity tests were rather uncommon (3.8%, n = 101). For multiple infections, beta-lactam antibiotics (such as amoxicillin and cefuroxime) were the most commonly prescribed antibiotics (2.26%, n = 60), followed by macrolides (such as azithromycin and Clindamycin) and fluoroquinolones (eg, ciprofloxacin and levofloxacin). Conclusion: Respiratory tract infections are the most prevalent infectious disease among hospital patients, who are primarily in their 20s. The frequency of performing culture tests is low. Therefore, it is important to promote culture sensitivity testing in order to support the prudent use of antibiotics. Guidelines for anti-microbial stewardship programs are also highly recommended.

Indexed as

antibioticsHail regioninfectionsprescribing patternSaudi Arabia

Identifiers

PMID37333682
PMCPMC10276591
OpenAlexW4380631678

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.